An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly Caucasian population.
暂无分享，去创建一个
A. Hofman | J. Witteman | T. Stijnen | C. V. van Duijn | H. Pols | S. Lamberts | O. Njajou | J. Janssen | I. Rietveld | M. Yazdanpanah
[1] A. Hofman,et al. A polymorphic CA repeat in the IGF‐I gene is associated with gender‐specific differences in body height, but has no effect on the secular trend in body height , 2004, Clinical endocrinology.
[2] A. Hofman,et al. Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study). , 2004, The American journal of cardiology.
[3] A. Maseri,et al. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. , 2001, Journal of the American College of Cardiology.
[4] A. Hofman,et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. , 2001, Diabetes.
[5] J. Sowers,et al. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. , 1999, Journal of molecular and cellular cardiology.
[6] P. Anversa,et al. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. , 1999, Circulation research.
[7] N. Pedersen,et al. Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. , 1996, The Journal of clinical endocrinology and metabolism.